Condensed Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended
Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenue	$ 54,763	$ 49,603
Cost of Goods and Services Sold	52,995	47,989
Gross margin	1,768	1,614
Operating expenses:
Distribution, selling, general and administrative expenses	1,197	1,197
Restructuring and employee severance	25	29
Amortization and other acquisition-related costs	64	71
Impairments and (gain)/loss on disposal of assets, net	537	153
Litigation (recoveries)/charges, net	(41)	27
Operating earnings/(loss)	(14)	137
Other (income)/expense, net	(2)	2
Interest expense, net	14	25
Earnings/(loss) before income taxes	(26)	110
Benefit from income taxes	(32)	(1)
Net earnings	6	111
Less: Net earnings attributable to noncontrolling interests	(1)	(1)
Net earnings attributable to Cardinal Health, Inc.	$ 5	$ 110
Earnings per common share attributable to Cardinal Health, Inc.:
Basic (in shares)	$ 0.02	$ 0.41
Diluted (in shares)	$ 0.02	$ 0.40
Weighted-average number of common shares outstanding:
Basic (in shares)	249	271
Diluted (in shares)	250	273
Cash dividends declared per common share	$ 0.5006	$ 0.4957

The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.

No definition available.